Search Results - "Kebabian, J W"

Refine Results
  1. 1

    Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys by Blanchet, P, Bédard, P J, Britton, D R, Kebabian, J W

    “…The motor effects of selective D-1 dopamine receptor stimulation in Parkinson's disease have been explored in a limited number of studies with partial D-1…”
    Get more information
    Journal Article
  2. 2

    Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine by Snyder, GL, Girault, JA, Chen, JY, Czernik, AJ, Kebabian, JW, Nathanson, JA, Greengard, P

    Published in The Journal of neuroscience (01-08-1992)
    “…The molecular mechanisms underlying regulation of fluid production by secretory epithelia such as the choroid plexus are poorly understood. Two cAMP-regulated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Compounds selective for dopamine receptor subtypes by Kebabian, John W., Tarazi, Frank I., Kula, Nora S., Baldessarini, Ross J.

    Published in Drug discovery today (01-08-1997)
    “…Novel dopamine (DA) receptor proteins of relatively low natural abundance and uncertain physiology can be expressed selectively in genetically transfected…”
    Get full text
    Journal Article
  5. 5

    A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets by Kebabian, J W, Britton, D R, DeNinno, M P, Perner, R, Smith, L, Jenner, P, Schoenleber, R, Williams, M

    Published in European journal of pharmacology (15-12-1992)
    “…A-77636, ((1R,3S) 3-(1'-adamantyl)-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benz opyran hydrochloride), is a selective dopamine D1 receptor agonist. In a…”
    Get more information
    Journal Article
  6. 6

    Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration by Britton, D R, Curzon, P, Mackenzie, R G, Kebabian, J W, Williams, J E, Kerkman, D

    Published in Pharmacology, biochemistry and behavior (01-08-1991)
    “…Rats trained to self-administer cocaine (0.75 mg/kg/infusion) on an FR-5 schedule were treated with selective D1 or D2 antagonists. A69045, a D1 antagonist…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Activation of the 5‐HT1c receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393 by Briggs, Clark A., Pollock, Nancy J., Frail, Donald E., Paxson, Cheryl L., Rakowski, Robert F., Kang, Chae Hee, Kebabian, John W.

    Published in British journal of pharmacology (01-12-1991)
    “…1 A cloned 5‐HT1C receptor expressed in Xenopus laevis oocytes was used to characterize the action of four dopamine D1‐selective benzazepines at the 5‐HT1C…”
    Get full text
    Journal Article
  9. 9

    Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors by Goldman, M E, Kebabian, J W

    Published in Molecular pharmacology (01-01-1984)
    “…The R(-) and the S(+) enantiomers of apomorphine (APO) and N-n-propyl norapomorphine (NPA) interact with both the D-1 and the D-2 dopamine receptors. R(-)-APO,…”
    Get more information
    Journal Article
  10. 10

    A mu-opiate receptor in 7315c tumor tissue mediates inhibition of immunoreactive prolactin release and adenylate cyclase activity by Frey, E A, Kebabian, J W

    Published in Endocrinology (Philadelphia) (01-01-1984)
    “…Cells of the 7315c tumor released immunoreactive PRL (IR-PRL). Cholera toxin enhanced this release. Morphine and other opiate agonists inhibited IR-PRL release…”
    Get more information
    Journal Article
  11. 11

    [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor by Sidhu, A, van Oene, J C, Dandridge, P, Kaiser, C, Kebabian, J W

    Published in European journal of pharmacology (09-09-1986)
    “…[125I]SCH 23982, [125I]8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol, binds reversibly and with high affinity (Kd = 0.7 +/- 0.05 nM) to…”
    Get more information
    Journal Article
  12. 12

    A phosphorylation cascade in the basal ganglia of the mammalian brain: regulation by the D-1 dopamine receptor. A mathematical model of known biochemical reactions by Kebabian, J W

    “…Stimulation of the dopamine D-1 receptor in the corpus striatum initiates a cascade of biochemical events. These events include: activation of adenylate…”
    Get more information
    Journal Article
  13. 13
  14. 14

    D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase by Cote, T E, Felder, R, Kebabian, J W, Sekura, R D, Reisine, T, Affolter, H U

    Published in The Journal of biological chemistry (05-04-1986)
    “…Stimulation of the D-2 dopamine receptor inhibits pro-opiomelanocortin (POMC) synthesis in isolated rat intermediate lobe tissue. Intermediate lobe tissue was…”
    Get full text
    Journal Article
  15. 15

    Two dopamine receptors: biochemistry, physiology and pharmacology by Stoof, J C, Kebabian, J W

    Published in Life sciences (1973) (03-12-1984)
    “…In 1979, two categories of dopamine (DA) receptors (designated as D-1 and D-2) were identified on the basis of the ability of a limited number of agonists and…”
    Get more information
    Journal Article
  16. 16

    Bromocriptine-induced changes in the biochemistry, physiology, and histology of the intermediate lobe of the rat pituitary gland by Beaulieu, M, Goldman, M E, Miyazaki, K, Frey, E A, Eskay, R L, Kebabian, J W, Cote, T E

    Published in Endocrinology (Philadelphia) (01-05-1984)
    “…Treatment of rats with 2-Br-alpha-ergocryptine (bromocriptine; CB 154) elicits biochemical, physiological, and histological changes in the intermediate lobe…”
    Get more information
    Journal Article
  17. 17

    Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930 by Britton, D R, Kebabian, J W, Curzon, P

    Published in European journal of pharmacology (23-07-1991)
    “…The present report describes the effects of sub-chronic treatment with l-dopa or with a recently characterized, selective dopamine D1 receptor agonist (A68930)…”
    Get more information
    Journal Article
  18. 18

    Brain dopamine receptors : 20 years of progress by KEBABIAN, J. W

    Published in Neurochemical research (1993)
    “…I present a brief overview of the contributions of Paul Greengard's laboratory to the field of dopamine receptor research. I show that the work on the…”
    Get full text
    Journal Article
  19. 19

    An iodinated ligand identifying the D-1 dopamine receptor by Sidhu, A, Kebabian, J W

    Published in European journal of pharmacology (31-07-1985)
    “…Iodination (with 125I) of SKF 83692 (2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol) produces a ligand of high specific activity. In the caudate…”
    Get more information
    Journal Article
  20. 20

    Rapid Changes in Rat Pineal β -adrenergic Receptor: Alterations in l-[3H]alprenolol Binding and Adenylate Cyclase by Kebabian, John W., Zatz, Martin, Romero, Jorge A., Axelrod, Julius

    “…The properties of the β -adrenergic receptor which regulates adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] in the pineal gland are…”
    Get full text
    Journal Article